| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.2 | 4e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |